newsfilter
← Latest News
ACCESS Newswire·

The WHO and USAN Adopt Generic Name for Edesa's ARDS Drug Candidate

International name assignment is a key step in Edesa's development and commercialization plansTORONTO, ON / ACCESSWIRE / April 4, 2023 / Edesa Biotech, Inc. , a clinical-stage biopharmaceutical company